334 related articles for article (PubMed ID: 22342779)
1. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose.
van Amsterdam JG; Brunt TM; McMaster MT; Niesink RJ
Neurosci Biobehav Rev; 2012 Apr; 36(4):1217-27. PubMed ID: 22342779
[TBL] [Abstract][Full Text] [Related]
2. [Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)].
van Amsterdam JG; Brunt TM; McMaster MT; Niesink R; van Noorden MS; van den Brink W
Tijdschr Psychiatr; 2012; 54(12):1001-10. PubMed ID: 23250641
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in the use of "club drugs": an Australian review.
Degenhardt L; Copeland J; Dillon P
Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
[TBL] [Abstract][Full Text] [Related]
4. [Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
Galldiks N; Kadow I; Bechdolf A; Fink GR; Klosterkötter J; Kuhn J
Fortschr Neurol Psychiatr; 2011 Jan; 79(1):21-5. PubMed ID: 21154180
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
Amsterdam JV; Brunt TM; Pereira FR; Crunelle CL; Brink WVD
Curr Neuropharmacol; 2022; 20(4):809-819. PubMed ID: 34151766
[TBL] [Abstract][Full Text] [Related]
6. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
7. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate (GHB): a newer drug of abuse.
O'Connell T; Kaye L; Plosay JJ
Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of GHB and ketamine use in an Australian household survey.
Degenhardt L; Dunn M
Int J Drug Policy; 2008 Aug; 19(4):311-6. PubMed ID: 17920826
[TBL] [Abstract][Full Text] [Related]
10. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
11. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.
Louagie HK; Verstraete AG; De Soete CJ; Baetens DG; Calle PA
J Toxicol Clin Toxicol; 1997; 35(6):591-4. PubMed ID: 9365424
[TBL] [Abstract][Full Text] [Related]
12. Gamma hydroxybutyric acid (GHB) intoxication.
Mason PE; Kerns WP
Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
[TBL] [Abstract][Full Text] [Related]
13. A brief overview of the clinical pharmacology of "club drugs".
Britt GC; McCance-Katz EF
Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
[TBL] [Abstract][Full Text] [Related]
14. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
Gahlinger PM
Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
[TBL] [Abstract][Full Text] [Related]
15. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
Hovda KE; Liberg JP; Nordby G; Jacobsen D
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of γ-hydroxybutyrate overdosing.
Korf DJ; Nabben T; Benschop A; Ribbink K; van Amsterdam JG
Eur Addict Res; 2014; 20(2):66-74. PubMed ID: 24080792
[TBL] [Abstract][Full Text] [Related]
17. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
Strange DG; Jensen D
Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats.
Pedraza C; García FB; Navarro JF
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1165-77. PubMed ID: 19288974
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
20. Should ethanol be scheduled as a drug of high risk to public health?
Sellman JD; Robinson GM; Beasley R
J Psychopharmacol; 2009 Jan; 23(1):94-100. PubMed ID: 18583435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
